ArticleFrontiers in public health2025
Trends and burden of gout among adolescents aged 10-24 years: insights from the global burden of disease study 2021.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The global landscape of pediatric hyperuricemia research: a bibliometric roadmap to mechanisms, management, and future therapeutics (1997-2024).Translational pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Gout increasingly affects adolescents. However, comprehensive data on adolescent gout are scarce. This study aimed to analyse the incidence, prevalence, years lived with disability (YLDs), and risk factors for gout in adolescents aged 10-24 years via the Global Burden of Disease (GBD) database from 1990 to 2021. Methods: This study employed cross-sectional data from the GBD 2021 study in adolescents aged 10-24 years. The incidence, prevalence, YLD, and risk factor rates or numbers for gout were extracted, and trends across different sociodemographic index (SDI) levels and exponential annualized percentage change (EAPC) rates were analysed via linear regression analysis. Bayesian age-period-cohot (BAPC) model with an integrated nested Laplace approximation to predict the age-standardized incidence rate of gout among adolescents over the next 15 years in Global, China, Taiwan (Province of China), Qatar, and Maldives. Results: The global incidence number of gout in adolescents increased by 23.47% (95% CI 21.66 to 25.92) from 1990 to 2021; by 2021, the incidence number of gout was 110664.59 (95% UI 62543.83 to 163447.37). High BMI was the leading risk factor for YLD. The higher the SDI is, the greater the incidence of gout and the greater the disease burden in adolescents. Taiwan (Province of China) had the highest rates in 2021, and an increasing trend is predicted by 2035. Conclusion: Adolescent gout is an escalating global health issue, particularly in regions with increasing age-standardized incidence rates. Urgent dietary and weight interventions are recommended to reduce the disease burden in adolescents.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.